Unknown

Dataset Information

0

Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.


ABSTRACT: Skin cutaneous melanoma (SKCM) is one of the most deadly malignancies. Although immunotherapies showed the potential to improve the prognosis for metastatic melanoma patients, only a small group of patients can benefit from it. Therefore, it is urgent to investigate the tumor microenvironment in melanoma as well as to identify efficient biomarkers in the diagnosis and treatments of SKCM patients. A comprehensive analysis was performed based on metastatic melanoma samples from the Cancer Genome Atlas (TCGA) database and ESTIMATE algorithm, including gene expression, immune and stromal scores, prognostic immune-related genes, infiltrating immune cells analysis and immune subtype identification. Then, the differentially expressed genes (DEGs) were obtained based on the immune and stromal scores, and a list of prognostic immune-related genes was identified. Functional analysis and the protein-protein interaction network revealed that these genes enriched in multiple immune-related biological processes. Furthermore, prognostic genes were verified in the Gene Expression Omnibus (GEO) databases and used to predict immune infiltrating cells component. Our study revealed seven immune subtypes with different risk values and identified T cells as the most abundant cells in the immune microenvironment and closely associated with prognostic outcomes. In conclusion, the present study thoroughly analyzed the tumor microenvironment and identified prognostic immune-related biomarkers for metastatic melanoma.

SUBMITTER: Han W 

PROVIDER: S-EPMC7685010 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.

Han Wei W   Huang Biao B   Zhao Xiao-Yu XY   Shen Guo-Liang GL  

Bioscience reports 20201101 11


Skin cutaneous melanoma (SKCM) is one of the most deadly malignancies. Although immunotherapies showed the potential to improve the prognosis for metastatic melanoma patients, only a small group of patients can benefit from it. Therefore, it is urgent to investigate the tumor microenvironment in melanoma as well as to identify efficient biomarkers in the diagnosis and treatments of SKCM patients. A comprehensive analysis was performed based on metastatic melanoma samples from the Cancer Genome A  ...[more]

Similar Datasets

| S-EPMC8084029 | biostudies-literature
| S-EPMC6875323 | biostudies-literature
| S-EPMC7450998 | biostudies-literature
| S-EPMC10998739 | biostudies-literature
| S-EPMC6885833 | biostudies-literature
| S-EPMC7982771 | biostudies-literature
| S-EPMC7138561 | biostudies-literature
| S-EPMC7668584 | biostudies-literature
| S-EPMC8181403 | biostudies-literature
| S-EPMC7202520 | biostudies-literature